Non-Executive Chair and Former Executive Chair and Interim CEO · BAXTER INTERNATIONAL INC (BAX)

Brent Shafer

FY2025 is the first fiscal year CompBrief holds for Brent Shafer as a named executive officer of BAXTER INTERNATIONAL; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$3,809,993

Compensation figures as of the proxy filed March 23, 2026 (DEF 14A).

Brent Shafer compensation by year

BAXTER INTERNATIONAL Summary Compensation Table · the one fiscal year held
In US dollars, as BAXTER INTERNATIONAL reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$701,644
Bonus$654,839
Stock awards$2,400,815
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$52,695
Total$3,809,993

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BAXTER INTERNATIONAL INC DEF 14A filed March 23, 2026, accession 0001628280-26-020330, and prior-year filings. Open the filing on EDGAR.

BAXTER INTERNATIONAL’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Andrew HiderPresident and CEO$29,805,182
Joel GradeFormer Executive Vice President and CFO$8,209,568
Jos AlmeidaFormer Chair of the Board, President and CEO$7,666,044
Heather KnightFormer Executive Vice President, COO and Interim Group President, Medical Products & Therapies$6,074,548
Reazur RasalExecutive Vice President and Group President, Healthcare Systems & Technologies$5,246,214
Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies$5,246,214
Alok SonigFormer Executive Vice President and Group President, Pharmaceuticals$5,239,273
Brent Shafer · this pageNon-Executive Chair and Former Executive Chair and Interim CEO$3,809,993
David RosenbloomExecutive Vice President and General Counsel$3,794,164
Maria SorianoGroup President, Infusion Therapies & Technologies and Pharmaceuticals$2,654,841

The full BAXTER INTERNATIONAL compensation record

free company brief

This page is one person within BAXTER INTERNATIONAL's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BAXTER INTERNATIONAL's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BAXTER INTERNATIONAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy